XML 38 R22.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes
12 Months Ended
Dec. 31, 2022
Income Taxes  
Income Taxes

Note 15.  Income Taxes

The provision (benefit) for income tax expense consisted of the following:

Year Ended December 31,

(In thousands)

    

2022

    

2021

    

2020

Current income taxes, Federal

$

1,838

$

(1,274)

$

(653)

Current income taxes, State

637

214

294

2,475

(1,060)

(359)

Deferred income taxes, Federal

 

(32)

 

7,874

 

(833)

Deferred income taxes, State

2,356

(395)

(32)

10,230

(1,228)

Unrecognized tax benefit, Federal

 

(50)

 

348

 

Unrecognized tax benefit, State

(54)

(50)

348

(54)

Total provision (benefit) for income taxes

$

2,393

$

9,518

$

(1,641)

The components of our deferred tax assets and liabilities were as follows:

At December 31,

(In thousands)

    

2022

    

2021

Deferred tax assets:

Operating lease liability

$

5,945

$

6,490

Net operating loss carryforwards

179

671

Accounts receivable and inventory reserves

6,013

4,658

Stock-based compensation

4,886

3,777

Accrued liabilities

 

1,914

 

1,104

Warranty reserves

1,071

1,245

Intangible assets

2,947

579

Business credits

536

682

R&D expenses

1,103

Other

 

183

 

199

Total deferred tax assets

24,777

19,405

Deferred tax liabilities:

Right-of-use asset

 

(5,425)

 

(6,019)

Fixed assets

(1,080)

(914)

Prepaid expenses

(251)

(378)

Other

(186)

(87)

Total deferred tax liabilities

(6,942)

(7,398)

Valuation allowance

(17,835)

(12,039)

Net deferred tax assets

$

$

(32)

A reconciliation of income tax (benefit) expense to the statutory federal tax rate is as follows:

Year Ended December 31,

    

2022

2021

2020

Tax expense at statutory rate

 

21.0

%  

21.0

%  

21.0

%

State income taxes, net of federal benefit

4.1

(1.1)

(7.9)

Executive compensation

(14.2)

(5.5)

Meals and entertainment

(10.6)

Incentive stock options

 

 

 

(0.4)

Employee Stock Purchase Plan

(1.0)

(7.5)

(8.6)

Federal business credits

1.6

10.9

Valuation allowance

(37.4)

(525.0)

8.0

Return to provision

(0.2)

(6.5)

3.6

Research and development credits

60.2

IRS exam

 

2.5

Deferred reprice - state

 

0.9

 

3.3

 

Federal carryback claim deferred rate differential

38.5

Unrecognized tax benefits

(0.3)

(2.2)

2.3

Excess benefit on non-qualified stock options and RSUs

(3.7)

47.2

28.0

Interest and penalties

(0.7)

1.9

Other

 

(0.5)

 

(0.5)

 

(0.2)

Net effective rate

 

(15.5)

%  

(415.1)

%  

72.6

%

A reconciliation of unrecognized tax benefits (“UTB”) is as follows:

December 31,

(In thousands)

    

2022

    

2021

    

2020

Balance beginning of the year

$

522

$

$

54

Gross change — tax positions in prior year

90

522

(54)

Balance end of the year

$

612

$

522

$

Deferred income taxes result from temporary differences between the reporting of amounts for financial statement purposes and income tax purposes. These differences relate primarily to different methods used for income tax purposes including depreciation and amortization, warranty and vacation accruals, and deductions related to allowances for doubtful accounts receivable, and inventory reserves.

As of December 31, 2022, the Company had approximately $179 thousand of state net operating loss ("NOL") carryforwards. The state NOL carryforward amounts expire beginning in tax years 2027 if not utilized.

The Company is subject to income tax examinations in the U.S. federal jurisdiction as well as in various state jurisdictions. U.S. federal and state tax years prior to 2019 are closed to examination. In the event of any future tax assessments, we have elected to record the income taxes and any related interest and penalties as income tax expense on our Consolidated Statement of Operations. The Company is not under exam in any jurisdictions.

We recognize the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more likely than not threshold, the amount recognized in the consolidated financial statements is the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the relevant tax authority.

Management assesses the available positive and negative evidence to estimate whether sufficient future taxable income will be generated to permit use of the existing deferred tax assets. A significant piece of objective negative evidence evaluated was the cumulative loss expected to be incurred over the three-year period ended December 31, 2022. Such objective evidence limits the ability to consider other subjective evidence, such as our projections for future growth.

On the basis of this evaluation, as of December 31, 2022, a valuation allowance of $17.8 million was recorded to recognize only the portion of the deferred tax assets that is more likely than not to be realized. The amount of the deferred tax assets considered realizable, however, could be adjusted if estimates of future taxable income during the carryforward period are reduced or increased or if objective negative evidence in the form of cumulative losses is no longer present and additional weight is given to subjective evidence such as our projections for growth.